#USA #Toronto #Clinical Trials #biorepository #Resonant Clinical Solutions

Resonant Clinical Solutions Unveils Groundbreaking Suite of Asset Management Programs

In a significant advancement for the life sciences sector, Resonant Clinical Solutions has launched a suite of asset management programs aimed at optimizing sample storage strategies for clinical trials. This announcement was made during the ISBER 2026 International Biospecimen Summit in Toronto, highlighting the evolving needs of life sciences organizations dealing with complex biorepository management.

The Challenge of Sample Management

As clinical programs become increasingly intricate and the need for high-quality data integrity rises, companies in the life sciences industry are finding themselves managing an ever-growing number of samples across diverse sites and vendors. With new advancements in therapies—particularly in cell and gene treatment—the pressure to maintain efficient and compliant storage solutions has never been greater. Christophe Berthoux, the CEO of Resonant Clinical Solutions, expressed concerns about how vital sample management is, noting that, "Research samples represent years of investment and, in many cases, irreplaceable science. Yet decisions about them are too often made by default rather than by design."

This intensifying landscape of clinical research drives the necessity for structured strategies surrounding sample storage, as choices made during this phase can significantly impact the efficiency and outcomes of clinical programs.

Introducing the Asset Management Programs

Resonant’s suite of programs is tailored to support clients according to their specific needs. Comprised of three distinct components—Remote Asset Management (RAM), Proactive Asset Management (PAM), and Strategic Asset Management (SAM)—these programs aim to cover a range of scenarios faced by life sciences organizations.

1. Remote Asset Management (RAM)

Designed for organizations that maintain their samples in-house, RAM allows Resonant experts to come directly to client facilities. These professionals assess current inventory, evaluate storage practices, and ensure compliant management. This service frees up valuable time and lab space for research and development teams, allowing them to focus on core scientific tasks instead of logistical concerns. The key features include digital cataloging, real-time inventory tracking, and expedited sample retrieval, significantly enhancing operational efficiency.

2. Proactive Asset Management (PAM)

For companies whose studies have concluded but whose sample inventory remains scattered, PAM provides an opportunity for consolidation. Resonant facilitates communication between client organizations and partner labs or CROs, ensuring all samples are safely and effectively transferred to a secure, long-term storage facility. This program culminates in a thoroughly validated inventory which simplifies future audits and planning for clinical studies.

3. Strategic Asset Management (SAM)

For those contemplating a shift in their storage strategy, SAM offers in-depth analysis of inventory costs and alternatives. Resonant evaluates the financial implications of potentially insourcing or transferring samples to other vendors. By breaking down various cost components—including staffing, compliance, and equipment—this program helps clients make informed decisions that balance operational efficiency with cost-effectiveness.

A Tailored Approach

Corey Stone, Vice President and General Manager of Biorepository at Resonant, emphasized the importance of customized solutions: "We designed this suite of programs to provide right-sized solutions for different client needs. We identify which program best fits a client's current scenario and bring the necessary expertise, infrastructure, and regulatory compliance to deliver reliable, efficient outcomes."

Availability and Contact Information

The entire suite of Sample Asset Management Programs is available immediately, catering to the diverse requirements of clients across the life sciences sector. For more thorough insights about these innovative programs, interested parties can visit resonantclinical.com/sample-asset-management or directly reach out via email at [email protected]. At ISBER 2026, Resonant will be exhibiting at booth #14, showcasing their commitment to enhancing clinical trial efficiency through better sample asset management.

About Resonant Clinical Solutions

Resonant Clinical Solutions serves as a global clinical solutions partner, assisting life sciences companies throughout the clinical supply chain and sample life cycle. The company manages over 100 million research assets and has facilitated more than 2,500 clinical trials. With a mission to simplify complexity and empower its partners, Resonant aims to allow researchers to focus on what truly matters: advancing science and enhancing patient care. For further information, visit resonantclinical.com.